Reta glucagon-like peptide-1 (GLP-1) receptor agonists provide a groundbreaking approach to diabetes management. These innovative therapies work by mimicking the physiological actions of GLP-1, a hormone secreted by the https://elainesbra383390.affiliatblogger.com/91157142/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes